GLUCOSE METABOLISM AFTER PANCREAS TRANSPLANTATION: CYCLOSPORINE VERSUS TACROLIMUS | Zendy

C. Dieterle | Zendy; Susanne Schmauss | Zendy; M. Veitenhansl | Zendy; B Gutt | Zendy; WolfDieter Illner | Zendy; W. Land | Zendy; Rüdiger Landgraf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

GLUCOSE METABOLISM AFTER PANCREAS TRANSPLANTATION: CYCLOSPORINE VERSUS TACROLIMUS

Author(s) -

C. Dieterle,

Susanne Schmauss,

M. Veitenhansl,

B Gutt,

WolfDieter Illner,

W. Land,

Rüdiger Landgraf

Publication year - 2004

Publication title -

transplantation

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.45

H-Index - 204

eISSN - 1534-6080

pISSN - 0041-1337

DOI - 10.1097/01.tp.0000129063.65446.65

Subject(s) - tacrolimus , transplantation , medicine , immunosuppression , endocrinology , pancreas transplantation , diabetes mellitus , insulin , islet , basal (medicine) , gastroenterology , kidney transplantation , urology

The results of the new immunosuppressants in simultaneous pancreas-kidney transplantation (SPK) concerning organ survival and rejection rates are excellent. Tacrolimus as well as cyclosporine are assumed to be diabetogenic; however, there are no comparative studies investigating their effects on glucose metabolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research